Tag: BOIRON
Boiron: The family shareholders will launch a takeover bid
Read also (CercleFinance.com) – The family shareholders of Boiron are preparing to launch a takeover bid (OPA) on the pharmaceutical laboratory in order to withdraw it from the stock market,…
BOIRON: Press release relating to the suspension of trading – 07/04/2023 at 12:00
In Messimy, July 4, 2023, at 12 p.m. BOIRON has asked Euronext to suspend the listing of its share (FR0000061129 – BOI) admitted to the Euronext market of Euronext Paris…
BOIRON: Declaration of voting rights as of March 31, 2023 – 04/07/2023 at 4:35 p.m.
April 7, 2023 Publication the number of shares making up the capital and the total number of voting rights (Articles L. 233-8 II of the Commercial Code and 223-16 of…
Boiron: strong increase in net income
By Christopher Voisin Published on 03/21/2023 at 5:58 p.m. Photo credit © ChaunuPictures (Boursier.com) — The operating…
Boiron: 56.4% increase in CEO net income in 2022
(CercleFinance.com) – Boiron publishes a turnover of 534 ME for the 2022 financial year, up 17.4% compared to 2021. At the same time, operating profit was up by 35.5%, at…
BOIRON: Declaration of voting rights on February 28, 2023 – 03/10/2023 at 2:20 p.m.
March 10, 2023 Publication the number of shares making up the capital and the total number of voting rights (Articles L. 233-8 II of the Commercial Code and 223-16 of…
BOIRON: Eligibility of BOIRON shares for PEA-PME – 01/04/2023 at 10:00 am
January 4, 2023 BOIRON Laboratories confirm that they meet the eligibility criteria the equity savings plan intended to finance small and medium-sized enterprises and medium-sized enterprises (PEA-PME) under Articles L.…
Boiron: 25% increase in nine-month sales – 10/21/2022 at 2:55 pm
(CercleFinance.com) – Boiron has posted cumulative sales since the start of the year up 25.2% (+21.3% at constant exchange rates), to 385.2 million euros, including increases 16.4% in France and…
Boiron: Sales of new Boiron products, particularly homeopathic ones, are soaring
(BFM Bourse) – Boiron returns to profit at the end of its first half. The Rhone laboratory is reaping the benefits of its diversification with the launch of new products.…
BOIRON: First-half 2022 results – 09/07/2022 at 5:45 pm
(Data subject to a limited review by the statutory auditors) The Board of Directors of Laboratoires BOIRON, meeting on September 7, 2022, established the half-year corporate and consolidated financial statements…
Boiron: increase in its turnover in the first half of 2022 – 09/07/2022 at 18:36
(AOF) – Boiron, the homeopathy specialist, recorded a turnover up 35.2% for the first half of 2022, to 256.762 million euros. Growth was 25.2% in France and 47.6% internationally. Net…
Boiron: strong increase in revenues
By Christopher Voisin Published on 07/21/2022 at 6:05 p.m. Photo credit © Reuters …